279 related articles for article (PubMed ID: 37384032)
1. Non-alcoholic fatty liver disease-related hepatocellular carcinoma.
Daher D; Dahan KSE; Singal AG
J Liver Cancer; 2023 Mar; 23(1):127-142. PubMed ID: 37384032
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Seif El Dahan K; Daher D; Singal AG
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S207-S219. PubMed ID: 36103899
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.
Geh D; Manas DM; Reeves HL
Hepatobiliary Surg Nutr; 2021 Jan; 10(1):59-75. PubMed ID: 33575290
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
Wong SW; Ting YW; Chan WK
JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.
Tan DJH; Ng CH; Lin SY; Pan XH; Tay P; Lim WH; Teng M; Syn N; Lim G; Yong JN; Quek J; Xiao J; Dan YY; Siddiqui MS; Sanyal AJ; Muthiah MD; Loomba R; Huang DQ
Lancet Oncol; 2022 Apr; 23(4):521-530. PubMed ID: 35255263
[TBL] [Abstract][Full Text] [Related]
6. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
Loomba R; Lim JK; Patton H; El-Serag HB
Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
[TBL] [Abstract][Full Text] [Related]
7. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
9. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Cholankeril G; El-Serag HB
Semin Liver Dis; 2023 Feb; 43(1):89-99. PubMed ID: 36216350
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges.
Teng YX; Xie S; Guo PP; Deng ZJ; Zhang ZY; Gao W; Zhang WG; Zhong JH
J Clin Transl Hepatol; 2022 Oct; 10(5):955-964. PubMed ID: 36304509
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link.
Chrysavgis L; Giannakodimos I; Diamantopoulou P; Cholongitas E
World J Gastroenterol; 2022 Jan; 28(3):310-331. PubMed ID: 35110952
[TBL] [Abstract][Full Text] [Related]
12. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
Bertot LC; Adams LA
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.
Tovoli F; Ferri S; Piscaglia F
Curr Pharm Des; 2020; 26(32):3909-3914. PubMed ID: 32348210
[TBL] [Abstract][Full Text] [Related]
14. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
15. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
16. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography.
Taru MG; Lupsor-Platon M
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627125
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
Wong CR; Nguyen MH; Lim JK
World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736
[TBL] [Abstract][Full Text] [Related]
18. NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options.
Foerster F; Gairing SJ; Müller L; Galle PR
J Hepatol; 2022 Feb; 76(2):446-457. PubMed ID: 34555422
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and management issues of NAFLD-related HCC: what we know so far.
Pugliese N; Alfarone L; Arcari I; Giugliano S; Parigi TL; Rescigno M; Lleo A; Aghemo A
Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):31-43. PubMed ID: 36576057
[TBL] [Abstract][Full Text] [Related]
20. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Said A; Ghufran A
World J Clin Oncol; 2017 Dec; 8(6):429-436. PubMed ID: 29291167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
